Sector consensus Atossa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 15:55:46 2026-08-14 EDT			5-day change	1st Jan Change
2.550 ^USD	-0.39%		+8.05%	-71.19%

08-07	Atossa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-28	Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in Er-Positive Breast Cancer	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
ATOSSA THERAPEUTICS, INC.	18.67	+617.95%	3
LONZA GROUP AG	681.13	+21.07%	23
REVOLUTION MEDICINES, INC.	221.9	+8.93%	21
BEONE MEDICINES AG	433.02	+24.62%	27
IQVIA HOLDINGS INC.	275.17	+16.27%	18
CELLTRION, INC.	264,708.89	+31.7%	24
ASCENDIS PHARMA A/S	267.87	+24.8%	18
MEDPACE HOLDINGS, INC.	581.83	+0.58%	12
EUROFINS SCIENTIFIC SE	72.53	+2.96%	14
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	281	+0.34%	14
ICON PUBLIC LIMITED COMPANY	185.56	+13.74%	16
PHARMARON BEIJING CO., LTD.	38.15	-22.33%	11
BIO-TECHNE CORPORATION	70.73	-2.31%	11
ABIVAX	138.97	+35.32%	6
PRAXIS PRECISION MEDICINES, INC.	623.68	+70.03%	19
APOGEE THERAPEUTICS, INC.	134.85	+0.22%	11
PROTAGONIST THERAPEUTICS, INC.	165.31	+6.58%	13
KYMERA THERAPEUTICS, INC.	130.91	+11.52%	22
IONIS PHARMACEUTICALS, INC.	89.33	+56.07%	21
TEMPUS AI, INC.	62.64	+20.24%	14
Average	13,459.11	+46.91%	16
Weighted average by Cap.	23,712.49	+17.33%	19